Floragenex, Inc.

Beaverton, OR Part of Sedia Biosciences Corporation

UEI
Y32FU3MMP6C5
CAGE
4HC46
Primary NAICS
541990 All Other Professional, Scientific, and Technical Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Corporate family
SAM.gov registration date
Physical address
9590 SW Gemini Dr, Beaverton, OR 97008, USA
Website
floragenex.com
Founded
2007
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $113,000
FY2025 $0
FY2024 $0
FY2023 $56,996

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $75,000
2 Department of Agriculture $38,000

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Floragenex, Inc., a small-business subsidiary of Sedia Biosciences Corporation based in Beaverton, Oregon, provides genomic and DNA sequencing services to federal research and resource-management agencies as a prime contractor on individual small-purchase task orders. Floragenex operates under Total Small Business set-asides and full-and-open procurements with no parent-vehicle relationships, serving niche analytical roles in fisheries science, forest genetics, and species identification across NOAA, USDA Forest Service, and USDA Agricultural Research Service portfolios.

Floragenex's core capability is DNA and RNA sequencing, transcriptome assembly, and species-identification analysis on environmental and biological samples. Representative awards include a $230,600 total-small-business purchase order from USDA Forest Service Region 4 (awarded September 2026, extending through May 2031) for genetic testing to identify whitebark pine and limber pine tree tissue samples supporting the Forest Inventory and Analysis program, with per-sample pricing and annual delivery of approximately 1,000 samples; a $75,000 total-small-business purchase order from NOAA (awarded September 2026) for methyl-RAD epigenetic sequencing of bluefin tuna, yellowfin tuna, and Atlantic sharpnose shark samples; and a $101,391 NOAA contract (awarded April 2022) for DNA next-generation sequencing of white perch supporting the Northeast Fisheries Science Center stock assessment mission.

NOAA dominates customer concentration, funding 7 awards worth $238 thousand combined potential value, accounting for 38% of all awards in the source data. USDA's Forest Service R4-Intermountain Region anchors the second-largest potential-value single award at $231 thousand. The vendor's top five customer agencies account for 89% of combined potential value across 15 awards. Floragenex holds no parent IDIQs, GWACs, or BPAs; all work flows through small-purchase orders under individual solicitations. Activity is sparse and episodic — two awards in 2026 following a multi-year trough — with combined potential value of $628 thousand across the full source history and $406 thousand obligated to date. One award reaches ultimate completion within the next twenty-four months, creating minimal recompete pressure. As a subsidiary, Floragenex operates separately from Sedia Biosciences Corporation, which holds its own CDC award history for HIV diagnostic kits and reagents unrelated to Floragenex's environmental-genomics mission.

Quick answers

Is Floragenex, Inc. registered in SAM.gov?

Yes. Floragenex, Inc.'s SAM.gov registration is active through May 28, 2027.

How much has Floragenex, Inc. received in federal contracts?

Federal contracts obligated $169,996 to Floragenex, Inc. in fiscal years 2023 through 2027.

What is Floragenex, Inc.'s most recent federal award?

Floragenex, Inc.'s most recent federal contract award is Methyl-RAD epigenetic sequencing services for provided samples of bluefin tuna, yellowfin tuna, and atlantic… (1333MF26P0131), from National Oceanic and Atmospheric Administration, on September 15, 2026.

On GovTribe

See Floragenex, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors